Schizophrenia - Search News

Schizophrenia, Bristol Myers Squibb

Bloomberg on MSN · 4d

Bristol Myers Says New Schizophrenia Drug Off to Strong Start

Bristol Myers Squibb Co. said its new schizophrenia drug is off to a better start than similar recently launched treatments, in an early sign that its $14 billion purchase of Karuna Therapeutics is paying off.

Hosted on MSN · 3d

Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the latter part of the year.

FDA approves first new schizophrenia drug in more than 30 years

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

Business Insider · 4d

Bristol Myers CEO says new drug Cobenfy effective in schizophrenia, CNBC reports

Bristol Myers (BMY) new psychiatric drug Cobenfy is effective in treating schizophrenia without “the serious side effects’ of other older

News Medical on MSN2d

Immune system changes may predict antipsychotic resistance in schizophrenia Scientis...

Researchers from the National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology ...

FierceBiotech2d

Boehringer's phase 3 schizophrenia program misses primary goal

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a ...

1d

Pandemic led to rapid adoption of telemental health for those with schizophrenia

For Medicaid beneficiaries with schizophrenia, delivery of mental health care through telehealth (telemental health care) ...

Novel Therapy Linked to Cognitive Benefit in Schizophrenia

Xanomeline/trospium chloride may help improve cognition in patients with acute schizophrenia and cognitive impairment, ...

How real stories are transforming schizophrenia narratives

Personal stories reshape schizophrenia perceptions by showing resilience and hope. Learn how these narratives challenge ...

Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS

Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and ...

8d

My Brother Has Schizophrenia. This Is How I Love Him.

Tim was always our artist. When he was 6, he started drawing comics, including one of a pig in a pen who was nonchalantly ...

Monthly Prescribing Reference1d

Iclepertin Fails to Improve Cognitive Impairment in Schizophrenia Trial

The CONNEX program consisted of the randomized, double-blind, placebo-controlled phase 3 CONNEX-1, CONNEX-2, and CONNEX-3 studies ...

2d

Boehringer provides update on iclepertin Phase III program in schizophrenia

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with ...

The American Journal of Managed Care2d

Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia

The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results